Lupus drug may shield fertility – new study investigates
NCT ID NCT05567198
First seen Apr 09, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This study looks at whether a drug called GnRHa can help preserve ovarian function in women under 40 with lupus who are treated with cyclophosphamide, a chemotherapy that can cause infertility. Researchers will survey 100 women about their menstrual history and review medical records to compare those who received GnRHa with those who did not. The goal is to understand if GnRHa reduces the risk of early menopause and infertility.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.